Amgen News
Most Popular Amgen Story
Denosumab could revive Amgen
Amgen's long search for a way to strengthen weak bones has led scientists to denosumab, a product that may stop tumors from spreading beyond soft tissue. And analysts are speculating that this... Read more...
Latest Headlines
- February 9, 2010
- February 2, 2010
- January 14, 2010
- January 4, 2010
- December 18, 2009
- December 16, 2009
- December 15, 2009
- December 10, 2009
- December 9, 2009
- November 20, 2009
- October 22, 2009
- October 19, 2009
- October 16, 2009
- October 15, 2009
- October 9, 2009
- September 22, 2009
- September 21, 2009
- September 17, 2009
- August 13, 2009
- August 13, 2009
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
